This web site is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

Zoenasa

Altheus Therapeutics, Inc.

Drug Names(s): Zoenasa-1:4, mesalamine + NFkB inhibitor

Description: Zoenasa is a fixed-dose combination of the anti-inflammatory mesalamine (5-aminosalicylic acid; 5-ASA), an aminosalicylate anti-inflammatory agent for gastrointestinal use, and a selective NFkB inhibitor.


Zoenasa News


Additional information available to subscribers only:

  • Targets
  • Routes
  • Catalysts
  • Designations
  • Events

Request a Free Demo Subscriber Login Search for another drug